Metabolic Health
Beyond Weight Loss: What GLP-1 Drugs May Be Doing to the Liver, the Brain's Reward System, and Older Patients
Three 2025 studies suggest the new generation of metabolic drugs reaches further than the scale — into addiction risk, liver fat, and the realities of treating people over 65. The evidence is promising, and still maturing.